A Comprehensive Review on Molecular Mechanism of HIF-1 alpha Pathway in Breast Cancer

Breast cancer is one of the most prevalent malignancies worldwide, characterized by uncontrolled cell proliferation, angiogenesis, invasion, and metastasis. Tumor hypoxia contributes significantly to breast cancer progression through the activation of hypoxia-inducible factor-1 alpha (HIF-1α), which regulates cellular adaptation to low oxygen conditions. This review highlights the molecular mechanisms of HIF-1α signaling and its involvement in tumor progression, angiogenesis, metastasis, and therapeutic resistance. Conventional treatment strategies, including chemotherapy, radiotherapy, and hormone therapy, are discussed alongside emerging peptide-based therapeutic approaches. Particular attention is given to peptide-based hormone therapy, receptor-targeted peptides, peptide receptor radionuclide therapy, peptide vaccines, anticancer peptides, and peptide-mediated drug delivery. Key molecular targets, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and HIF-1α, are examined. The review further explores hypoxia-associated metabolic adaptations, transcriptional regulation, apoptosis, cell proliferation, and tumor survival pathways. Molecular docking is highlighted as a promising approach for identifying potential anticancer therapeutic candidates. Additionally, advanced peptide delivery systems involving cell-penetrating peptides, chitosan, sodium alginate, biocompatible polymers, and nanoparticles are discussed for improving targeted delivery and therapeutic efficacy. Animal models are also considered for evaluating treatment strategies. Overall, integrating HIF-1α-targeted interventions with peptide-based drug delivery may offer promising opportunities for developing innovative breast cancer therapies.

Authors

Institutions

Publication Details

Journal
IOASD Journal of Medical and Pharmaceutical Sciences
Published
2026-11-16
DOI
https://doi.org/10.67224/ioasdjmps.2026.v03i04.014
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Comprehensive Review on Molecular Mechanism of HIF-1 alpha Pathway in Breast Cancer

Dharmar Manimaran, Namasivayam Elangovan, Kalimuthu Tulasi Ramakrishnan, Kowsalya Rengasamy
1 links
IOASD Journal of Medical and Pharmaceutical Sciences
Cancer, Hypoxia, and Metabolism
article

A Comprehensive Review on Molecular Mechanism of HIF-1 alpha Pathway in Breast Cancer

Dharmar Manimaran, Namasivayam Elangovan, Kalimuthu Tulasi Ramakrishnan, Kowsalya Rengasamy
article en

Abstract

Breast cancer is one of the most prevalent malignancies worldwide, characterized by uncontrolled cell proliferation, angiogenesis, invasion, and metastasis. Tumor hypoxia contributes significantly to breast cancer progression through the activation of hypoxia-inducible factor-1 alpha (HIF-1α), which regulates cellular adaptation to low oxygen conditions. This review highlights the molecular mechanisms of HIF-1α signaling and its involvement in tumor progression, angiogenesis, metastasis, and therapeutic resistance. Conventional treatment strategies, including chemotherapy, radiotherapy, and hormone therapy, are discussed alongside emerging peptide-based therapeutic approaches. Particular attention is given to peptide-based hormone therapy, receptor-targeted peptides, peptide receptor radionuclide therapy, peptide vaccines, anticancer peptides, and peptide-mediated drug delivery. Key molecular targets, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and HIF-1α, are examined. The review further explores hypoxia-associated metabolic adaptations, transcriptional regulation, apoptosis, cell proliferation, and tumor survival pathways. Molecular docking is highlighted as a promising approach for identifying potential anticancer therapeutic candidates. Additionally, advanced peptide delivery systems involving cell-penetrating peptides, chitosan, sodium alginate, biocompatible polymers, and nanoparticles are discussed for improving targeted delivery and therapeutic efficacy. Animal models are also considered for evaluating treatment strategies. Overall, integrating HIF-1α-targeted interventions with peptide-based drug delivery may offer promising opportunities for developing innovative breast cancer therapies.

IOASD Journal of Medical and Pharmaceutical SciencesVol. 3(4)
Periyar University (IN), KS Rangasamy College of Arts and Science (IN)
Good health and well-being
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon